## 

## 

|||||Page No.|
|---|---|---|---|---|
|Legal and administrative||information|||
|Directors' report||||2-9|
|Independent|Examiner's|report||10|
|Consolidated|Statement|of Financial|Activities||
|Consolidated|and Charity|Balance Sheets|||
|Consolidated|and Charity|Statements|ofCash Flows||
|Notes to the|Financial Statements|||14-24|





## 

## 

## 

## 

## 

## 



## 



## 

## 



## 

## 

## 



|The following<br>is a summa|ry<br>of reserv|es at 31Dec|
|---|---|---|
|Restricted funds:||f|
|Clulow legacy (including|interest)|116,744|
|Other grants etc||307,028|
|PLC Seminar||834|
|Designated<br>funds:||f|
|ASM||137,676|
|SIGS||97,506|
|Map ofMedicine||7,774|
|General funds:||f|
|Invested<br>in fixed assets||1,879|
|Free reserves||249,035|
|Total||918,476|





## 

## 

## 

## 

## 






## 



## 

## 

## 

|||||Unrestricted|Restricted|TOTAL|TOTAL|
|---|---|---|---|---|---|---|---|
||||Notes|Funds|Funds|2023|2022|
|||||f|f|f|f|
|Income from:||||||||
|Donations<br>and legacies||||118,440||118I440|191,880|
|Income from charitable|activities|||40,580||40,580|40,309|
|income from other trading||activities||||||
|Commercial<br>trading operations||||57,842||57,842|38,275|
|Investment<br>income-interest||received||18,332||18,332|5,780|
|Total income||||235,194||235,194|276,244|
|Expenditure<br>on:||||||||
|Raising Funds||||||||
|Commercial<br>trading operations||||5,100||5,100|41,668|
|Charitable<br>activities||||244,011|(10)|244,001|233,043|
|Total Expenditure||||249,111|(10)|249,101|274,711|
|Net income/(expenditure)||for the year||(13,917)|10|(13,907)|1,533|
|Gross transfers<br>between|funds|||||||
|Net movement<br>in funds||||(13,917)|10|(13,907)|1,533|
|Reconciliation<br>offunds:||||||||
|Total Funds at 1January|2023|||507,787|424,596|932,383|930,850|
|Total Funds at 31December 2023||||493,870|424,606|918,476|932,383|





## 

## 

|AS AT31DECEMBE|R 2023||||||
|---|---|---|---|---|---|---|
||||Consolidated||Charity||
|||Note|2023|2022|2023|2022|
||||E|E|f||
|Fixed assets|||||||
|Tangible assets||12|1,879|3,708|1,879|3,708|
|Investments||13|||1|1|
||||1,879|3,708|1,880|3,709|
|Current assets|||||||
|Debtors|||15,265|4,366|89,287|20,613|
|Cash at bank and in|hand||1,063,405|1,031,803|985,699|1,012,768|
|Total current assets|||1,078,670|1,036,169|10741986|1 033 381|
|Creditors: amounts|falling due||||||
|within one year||15|(162,073)|(107,494)|(159,490)|(103,339)|
|Net Current assets|||916,597|928,675|915,496|930,042|
|Net assets|||918,476|932,383|917,376|933,751|
|Funds ofthe charity|||||||
|Restricted income funds|||424,606|424,596|424,606|424,596|
|Unrestricted<br>income|funds:||||||
|Designated<br>funds|||242,956|245,299|242,956|245,299|
|General funds|||250,914|262,488|249,814|263,856|
||||493,870|507,787|492,770|509,155|
|Total charity funds|||918,476|932,383|917,376|933,751|






## 

||||Consolidated|Consolidated|Charity||
|---|---|---|---|---|---|---|
||||2023|2022|2023|2022|
||||E|f|E|E|
|Net cash flow from operating||activities|13,270|5,806|(45,401)|(31,094)|
|Cash flow from investing|activities||||||
|Interest received|||18,332|5,780|18,332|5,780|
|Net cash flow from investing|activities||18,332|5,780|18,332|5,780|
|Cash flows from financing activities|||||||
|Net increase/(decrease)|in cash and cash||||||
|equivalents|||31,602|11,586|(27,069)|(25,314)|
|Cash and cash equivalents|at|13anuary 2023|1,031,803|1,020,217|1,012,768|1,038,082|
|Cash and cash equivalents|at|31December 2023|1,063,405|1,031,803|985,699|1,012,768|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

|Financial performance<br>|of|the charity|the charity|the charity||
|---|---|---|---|---|---|
|A summary<br>performance||ofthe charity excluding the results of its wholly owned subsidiary<br>is:||||
|||||2023|2022|
|||||E|E|
|Incoming resources||||177,352|237,969|
|Income from subsidiary|company||paid under licence|6,550||
|Donation ofprofits under||gift aid||43/724||
|||||227,626|237,969|
|Expenditure<br>on charitable||activities||244/001|233,043|
|Net expenditure||||(16,375)|4,926|



## 

||||||2023|2022|
|---|---|---|---|---|---|---|
||||||E|E|
||Donations||||583|743|
||Gift aid received|||||2|
||Grants|||||53,960|
||Subscriptions||||117,857|137,175|
||||||118,440|191,880|
|5|Income from charitable||activities||||
||||||2023|2022|
||||||E|E|
||Meeting income|||||6,668|
||SIGS||||26,720|20,682|
||Other income including||royalties||13,860|12,959|
||||||40,580|40,309|
|6|Other trading activities||- BPSPain Business Ltd||||
||||||2023|2022|
||||||E|E|
||Income generated|by BPS Pain Business||Ltd|57,842|38,275|



|||||2023|2022|
|---|---|---|---|---|---|
|||||E|E|
|Turnover||||57,842|38,275|
|Cost ofsales and||administration|costs|(5,100)|(41,668)|
|Costs recharged||by the charity|under licence|(6,550)||
|Operating|(loss)|/ profit||46,192|(3,393)|
|Donation|under|gift aid to The|British Pain Society|(43,724)||
|Retained|in subsidiary|||2,468|(3,393)|
|Aggregate|assets|||1,101|(1,368)|





## 

|7|Expenditure<br>o|n charita|ble|a|ctivities|||
|---|---|---|---|---|---|---|---|
|||||||2023|2022|
|||||||f|f|
||Staff costs|||||195|68,040|
||Direct costs|||||124,810|65,991|
||Support costs|||||107,365|83,674|
||Governance<br>costs|||||11,631|15,338|
|||||||244,001|233,043|
|||||||2023|2022|
|||||||f|f|
||Direct costs:|||||||
||Research grants|||||(10)|200|
||ASM costs|||||10,030|12,578|
||Other meeting|costs||||71,061|19,604|
||Newsletter<br>and Journal|||||43,729|33,609|
|||||||124,810|65,991|
||5upport costs:|||||||
||Property costs|||||66,847|33,657|
||Office costs|||||15,053|14,054|
||Computer<br>system and||software|||5,032|9,788|
||Insurance|||||3,001|3,565|
||Doubtful debts|||||(2,186)|3,287|
||Accountancy|||||9,355|15,264|
||Depreciation|||||469|927|
||Loss on disposal ofassets|||||1„360||
||Legal and professional||fees|||8,434|3,132|
|||||||107,365|83,674|
||Governance<br>costs:|||||||
||Council expenses|||||8,919|10,820|
||Induction<br>and|training|of|trustees|||1,998|
||Independent|examination||||2,712|2,520|
|||||||11,631|15,338|
|8|Net income/(expenditure)||||for the year|||
||This is stated|after charging:||||||
|||||||2023|2022|
|||||||f|f|
||Depreciation|||||469|927|
||Operating<br>lease payments|||||12,959|16,837|
||Independent|Examiner's||remuneration:||||
||Accountancy|services||||1,592|1,480|
||Independent|Examination|||Fees|1,120|1,040|





## 

## 

## 

## 

## 

## 

|||2023|2022|
|---|---|---|---|
|||f|f|
|Clulow award costs||(10)||
|Research grant costs|||200|
|Total grants and bursaries|awarded:|(10)|200|



|During<br>the year this|event|was|wholly|outsourced|to Kenes|International|Organizers<br>of Congresses<br>SA. A|Organizers<br>of Congresses<br>SA. A|
|---|---|---|---|---|---|---|---|---|
|summary<br>performance|ofthe|annual conference:|||||||
||||||||2023|2022|
||||||||f|f|
|incoming<br>resources|||||||268,100|228,530|
|Expenditure<br>incurred|||||||245,114|233,130|
|Net income / (expenditure)|||||||22,986|(4,600)|





|No charity trustee<br>received<br>a salary, benefits or any <br>nil). The management<br>services are now outsourced.<br>personnel<br>were:|other payment<br>for services supplied to the <br>The costs of staff which<br>all relate to key|charity (2022<br> management|
|---|---|---|
||2023|2022|
||E|E|
|Salaries and wages||56,668|
|Social security costs||1,756|
|Pension costs||6,057|
|||64,481|



|The total||cost of running<br>the council excluding<br>ASM costs wa|s as follows:||
|---|---|---|---|---|
||||2023|2022|
||||E|E|
|Meeting|-|Catering|1,965|1,332|
|Meeting|-|Room Hire / Telecoms|408|354|
|Meeting|-|Travelling|4,042|2,631|
||||6,415|4,317|



## 



## 

|OR <br>12|THE YEAR ENDED 31 DECEMBER <br>Tangible fixed assets (Group and|2023<br> charity)|||||
|---|---|---|---|---|---|---|
|||||Office|Fixtures &||
|||||Equipment<br>f|Fittings<br>f|Total<br>f|
||Cost:||||||
||As at 1January 2023|||10,397|10,063|20,460|
||Disposals|||(6,857)|(1,849)|(8,706)|
||As at 31December 2023|||3,540|8,214|11,754|
||Depreciation:||||||
||As at 1January 2023|||7,699|9,053|16,752|
||Charge for the year|||278|191|469|
||Disposals|||(5,549)|(1,797)|(7,346)|
||As at 31December 2023|||2,428|7,447|9,875|
||Net book value:||||||
||As at 31December 2023|||1,112|767|1,879|
||As at 31December 2022|||2,698|1,010|3,708|
|13|Fixed asset investment||||||
|||||Group|Charity||
||||2023|2022|2023|2022|
||||f|f|f|f|
||Wholly owned subsidiary||||||
||BPS Pain Business Ltd: 1ordinary|share ofE1|||||



## 

|Debtors|||||
|---|---|---|---|---|
||Group||Charity||
||2023|2022|2023|2022|
||f|E|f|f|
|Operationalinvoices|7,800|3,422|||
|Amounts<br>owed by group undertakings|||81,822|19,669|
|Prepayments|4,363|944|4,363|944|
|Other debtors|3,102||3,102||
||15,265|4,366|89,287|20,613|





## 

||||Group||Charity||
|---|---|---|---|---|---|---|
||||2023|2022|2023|2022|
||||f||f|f|
|Trade creditors|||47,377|13,992|45,936|11,560|
|Subscriptions|Advanced|Payments|73,800|42,158|73,800|42,158|
|Other creditors|||4,564|7,451|4,564|7,451|
|Accruals for|grants payable||30,000|35,000|30,000|35,000|
|Accruals|||6,250|8,260|5,190|7,170|
|Taxation and|VAT||82|633|||
||||162,073|107,494|159,490|103,339|



## 

|Analysis of|charitable<br>funds|||||||
|---|---|---|---|---|---|---|---|
|||||Net||Balance||
|2023||Income<br>f|Expenditure<br>f|income<br>f|Transfers<br>f|01.01.23<br>f|31.12.23<br>f|
|Restricted funds||||||||
|Clulow legacy|||10|10||116,734|116,744|
|Grants||||||307,028|307,028|
|PLCSeminar||||||834|834|
||||10|10||424,596|424,606|
|Designated|funds|||||||
|SIGS||47,489|(23,968)|23,521|(17,588)|91,573|97,506|
|Map of Medicine Pathways||||||7,774|7,774|
|ASM|||(8,276)|(8,276)||145,952|137,676|
|||47,489|(32,244)|15,245|(17,588)|245,299|242,956|
|General fund||129,863|(211,767)|(81,904)|67,862|263,856|249,814|
|Total funds|ofthe charity|177I352|(244 001)|(66I649)|50 27 I|933 751|917376|
|BPSPain Business Ltd||57,842|(5,100)|52,742|(50,274)|(1,368)|1,100|
|Total funds||235,194|(249,101)|(13,907)||932,383|918,476|





|THE YEAR ENDED 31DECEM<br> Analysis ofcharitable funds|BER 2023<br> (continued)||||||
|---|---|---|---|---|---|---|
||||Net||Balance||
||Income|Expenditure|income|Transfers|01.01.22|31.12.22|
|2022||E|||||
|Restricted funds|||||||
|Clulow legacy|||||116734|116,734|
|Grants|50,000|(200)|49800||257,228|307,028|
|Pain Education SIG|3,960|(4,080)|(120)|120|||
|PLCSeminar|||||834|834|
||53960|(4,280)|49,680|120|374796|424,596|
|Designated funds|||||||
|SIGS|20~682|(12'471)|8,211|(120)|83482|91,573|
|Map of Medicine Pathways|||||7,774|7774|
|ASM|6,668|(12,578)|(5910)||151,862|145,952|
||27,350|(25049)|2,301|(120)|243,118|245299|
|Generalfund|156,659|(203714)|(47,055)||310,911|263,856|
|Totalfunds ofthe charity|237,969|(233,043)|4,926||928,825|933,751|
|BPSPain Business Ltd|38275|(41,668)|(3,393)||2,025|(1,368)|
|Totalfunds|276,244|(274,711)|1,533||930,850|932,383|



## 

## 

## 

## 

## 



## 

|Analysis of net asset<br>|s between funds||||||||
|---|---|---|---|---|---|---|---|---|
|onsolidated||General|Designated||Unrestricted||Restricted|Total|
|||f||f||Total<br>f|f|f|
|2023<br>Fixed assets<br>Current assets||1,879<br>381,108||242,956||1,879<br>624,064|454,606|1,879<br>1,078,670|
|Creditors: amounts<br>one year|falling due within|(132,073)||||(132(073)|(30000)|(162I073)|
|Net assets||250914||242~956||493I870|424 606|918,476|
|2022<br>Fixed assets<br>Current assets||3708<br>331,274||245299||3,708<br>576573|459,596|3708<br>1,036,169|
|Creditors: amounts <br>one year|falling due within|(72494)||||(72,494)|(35000)|(107,494)|
|Net assets||262,488||245299||507,787|424,596|932,383|
|Charity|||||||||
|2023<br>Fixed assets<br>Current assets||1,880<br>377,424||242,956||1,880<br>620,380|454,606|1,880<br>1,074,986|
|Creditors: amounts<br>one year|falling due within|(129,490)||||(129,490)|(30,000)|(159,490)|
|Net assets||249,814||242,956||492,770|424,606|917,376|
|2022<br>Fixed assets<br>Current assets||3,709<br>328,486||245299||3,709<br>573785|459,596|3,709<br>1,033,381|
|Creditors: amounts falling due within<br>one year<br>(68339)||||||(68,339)|(35000)|(103339)|
|Net assets||263856||245299||509,155|424,596|933,751|
|8 Gross obligations<br>under operating<br>As at 31 December 2023the group||leasing agreements<br> had future<br>minimum||lease commitments<br>as follows:<br>2023||||2022|
||||||||f|f|
||||||||Total|Total|
|Not later than 1year<br>Later than 1year and not later than||5years|||||15,000<br>28,750<br>43,750|16,837<br>49,108<br>65,945|





## 

|Reconciliation<br>of|net|m|ove|me|nt<br>in funds|to net cash|flow from operatin|g<br>activities|||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||Group||Charity||
||||||||2023|2022|2023|2022|
||||||||E||E|E|
|Net movement<br>in|funds||||||(13,907)|1,533|(16,375)|4,926|
|Add back: depreciation|||charge||||469|927|469|927|
|Add back: loss on disposal|||||||1,360||1,360||
|Interest received|||||||(18,332)|(5,780)|(18,332)|(5,780)|
|Decrease/(increase)||in|debtors||||(10,899)|23,244|(68,674)|4,171|
|Increase/(decrease)||in|creditors||||54,579|(14,118)|56,151|(35,338)|
|Net cash used in operating||||activities|||13,270|5,806|(45,401)|(31,094)|
|Financial instruments|||||||||||
|Categorisation<br>of|financial|||instruments|||||||
||||||||Group||Charity||
||||||||2023|2022|2023|2022|
||||||||E|E|E|E|
|Financial assets that||are debt|||instrument|measured|||||
|at amortised<br>cost|||||||1,074,307|1,035,225|1,070,623|1,032,437|
|Financial<br>liabilities|measured||||at amortised|cost|162,073|107,494|159,490|103,339|



##